SEC Form 4 · accession 0001645627-17-000131
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Oct 19, 2017
Accepted (ET)
Oct 26, 2017 · 11:55 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 19, 2017 | P | 2,000 | $0.0675 | A | 23,876,189 | D | |
| Common Stock | Oct 19, 2017 | P | 2,000 | $0.067 | A | 23,878,189 | D | |
| Common Stock | Oct 19, 2017 | P | 2,000 | $0.063 | A | 23,880,189 | D | |
| Common Stock | Oct 19, 2017 | P | 2,000 | $0.0632 | A | 23,882,189 | D | |
| Common Stock | Oct 19, 2017 | P | 2,000 | $0.062 | A | 23,884,189 | D | |
| Common Stock | Oct 19, 2017 | P | 2,000 | $0.0628 | A | 23,886,189 | D | |
| Common Stock | Oct 19, 2017 | P | 2,000 | $0.0628 | A | 23,888,189 | D | |
| Common Stock | Oct 19, 2017 | P | 2,000 | $0.0628 | A | 23,890,189 | D | |
| Common Stock | Oct 19, 2017 | P | 2,000 | $0.0628 | A | 23,892,189 | D | |
| Common Stock | Oct 19, 2017 | P | 1,000 | $0.0635 | A | 23,893,189 | D | |
| Common Stock | Oct 19, 2017 | P | 2,000 | $0.067 | A | 23,895,189 | D | |
| Common Stock | Oct 19, 2017 | P | 2,000 | $0.067 | A | 23,897,189 | D | |
| Common Stock | Oct 19, 2017 | P | 2,000 | $0.063 | A | 23,899,189 | D | |
| Common Stock | Oct 19, 2017 | P | 5,000 | $0.063 | A | 23,904,189 | D | |
| Common Stock | Oct 19, 2017 | P | 2,000 | $0.063 | A | 23,906,189 | D | |
| Common Stock | Oct 19, 2017 | P | 2,000 | $0.063 | A | 23,908,189 | D | |
| Common Stock | Oct 19, 2017 | P | 2,000 | $0.063 | A | 23,910,189 | D | |
| Common Stock | Oct 19, 2017 | P | 2,000 | $0.063 | A | 23,912,189 | D | |
| Common Stock | Oct 19, 2017 | P | 2,000 | $0.063 | A | 23,914,189 | D |
Table II — derivative securities
No Table II lines on this filing.